William Betts
Psychiatric/Mental Health · Eugene, ORNPI 1639458409
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $33,688 of the $41,101 with a category attached, or 82.0%. AbbVie accounts for 98.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2021 at $15,113 and has fallen 99.9% since, to $19 in 2025. Among psychiatric/mental health clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 188 payments — averaging $218.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$40K
- Teva Pharmaceuticals USA, Inc.$295
- Otsuka America Pharmaceutical, Inc.$64
- Lundbeck LLC$53
- Johnson & Johnson$36
- Vanda Pharmaceuticals Inc.$36
- plus $174 from 7 others
What the payments were for
- Speaking & faculty fees$33,68882%
- Travel & lodging$5,02912%
- Food & beverage$2,3846%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 142 | $40,443 |
| Teva Pharmaceuticals USA, Inc. | 31 | $295 |
| Otsuka America Pharmaceutical, Inc. | 2 | $64 |
| Lundbeck LLC | 3 | $53 |
| Johnson & Johnson | 1 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
| Alkermes, Inc. | 2 | $34 |
| Eisai Inc. | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Corium, LLC | 1 | $22 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$38,944
How this compares
$41,101 in reported general payments places this provider in the 95th percentile of 540 psychiatric/mental health providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 26 | $567 |
| Aripiprazole | 18 | $529 |
| Quetiapine Fumarate | 41 | $463 |
| Bupropion XlBupropion Hcl | 28 | $446 |
| Lamotrigine | 22 | $336 |
| Clonazepam | 31 | $221 |
| Buspirone Hcl | 16 | $200 |
| Trazodone Hcl | 20 | $186 |
| Alprazolam | 23 | $148 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $141 |
| Duloxetine Hcl | 12 | $119 |
| Lithium Carbonate | 26 | $97 |
| Sertraline Hcl | 16 | $88 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Eugene
- Karla MarvichEugene$5K
- Mary LeydaEugene$5K
- Christopher WorltonEugene$3K
- James AkinsEugene$3K
- Rose BoscainoEugene$2K
- Katherine LeathermanEugene$2K
- Alyssa LindEugene$2K
- Amber BensonEugene$2K
- Kara PetredisEugene$1K
- April DvorakEugene$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.